Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation

Pakistan Journal of Pharmaceutical Sciences

Volumn 26, Issue 2, 2013, Pages 323-332

  Akram, Muhammad ^a   Naqvi, Syed Baqir Shyum ^a   Khan, Ahmad ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Drug release kinetics and iontophoresis; Emu Oil; Factorial design; Insulin delivery; Transdermal emulgel

Indexed keywords

CARBOMER; GLUCOSE; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; INSULIN EMULGEL; KETAMINE; PENETRATION ENHANCING AGENT; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; EVALUATION; FACTORIAL DESIGN; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VITRO STUDY; IONTOPHORESIS; NONHUMAN; RABBIT; RAT;

ACRYLIC RESINS; ADMINISTRATION, CUTANEOUS; ANIMALS; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; EMULSIFYING AGENTS; GELS; HYPOGLYCEMIC AGENTS; INSULIN; IONTOPHORESIS; KINETICS; METHYLCELLULOSE; MODELS, BIOLOGICAL; MYRISTATES; OILS; PERMEABILITY; POLYSORBATES; RABBITS; RATS; SKIN; SKIN ABSORPTION; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84878101322     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. American Emu Association (1997). AEA Oil Standards Team. International Emu Oil Standards. Revision 2. May 1998. http://www.uniquelyemu.com/article13. htm
2. Minnaar M. Introduction to emu oil: Fats and oils in human health. In: Minnaar P, Minnaar M, Minnaar P. The Emu Farmers Handbook. Vol 1. Groveton, TX: Myoni Publishing Co.
3. Aoki M, Kameta A, Yoshioka I and Matsuzaki T (1956). Application of surface active agents to pharmaceutical preparations I: Effect of Tween 20 upon the antifungal activities of p-hydroxybenzoic acid esters in solubilized preparations [in Japanese]. J. Pharm. Soc. Jpn., 76: 939-943.
4. Banker GS and Rhodes CT (2007). Modern Pharmaceutics. Marcel Dekker Inc, Fourth edition, pp. 607, 626.
5. Barry BW (1983). Dermatological Formulations: Percutaneous Absorption, Marcel Dekker, New York, USA.
6. Barry BW and Bennett L (1987). Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progestrone. J. Pharm. Pharmacol., 39: 535-548.
7. Bolton S (1990). Pharmaceutical Statistics. Marcel Decker Inc., Second edition, p.234.
8. Brand RM and Iversen PL (1996). Iontophoretic delivery of a telomeric digonucleotide. Pharm.Res., 13:851-854.
9. David W Galbraith, Hans J Bohnert and Don P Bourque (1995). Methods in Cell Biology. Volume 49. Methods in Plant Cell Biology, Part A. Published by Academic Press Limited London, UK, pp.262.
10. Eccleston GM (1992). Emulsions. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. Vol.5, Marcel Dekker Inc., New York, USA, pp.137188.
11. Elias PM (1983). Epidermal lipids, barrier function and desquamation. J. Invest. Dermatol., 80: 44-49.
12. Fang JY, Fang CL and Huang YB (1997). Transdermal iontopheresis of sodium nonivaride acetate III: combined effect of pretreatment by penetration enhancers. Intl. J. Pharm., 149: 183-195.
13. Flynn GL (1985). In: Percutaneous absorption. Bronaugh RL, Maibach HI (Eds.), Marcel Dekker Inc., New York, USA, pp.17-52.
14. Franz RM, Browne JE and Lewis AR (1988). Experiment design, modeling and optimization strategies for product and process development. In: Libermann HA, Reiger MM, Banker GS (eds.), Pharmaceutical Dosage Forms: Disperse Systems. Vol.1, Marcel Dekker Inc., New York, USA, pp.427-519.
15. Goodman M and Barry BW (1988). Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. J. Invest. Dermatol., 91: 323-327.
16. Gungor S and Bergisadi N (2004). Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin. Pharmazie, 59: 39-41.
17. Hayton WL and Chen T (1982). Correction of perfusate concentration for sample removal. J. Pharm. Sci., 71: 820-821.
18. Jiang SJ and Zhou XJ (2003). Examination of the mechanism of oleic acid-induced percutaneous penetration enhancement: an ultrastructural study. Biol. Pharm. Bull., 26: 66-68.
19. Karakatsani M, Dedhiya M and Plakogiannis FM (2010). The effect of permeation enhancers on the viscosity and the release profile of transdermal hydroxypropyl methylcellulose gel formulations containing diltiazem HCl. Drug Dev. Ind. Pharm., 36(10): 1195-1206.
20. Kari B (1986). Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin. Diabetes, 35(2): 217-221.
21. Kasting GB, Smith RL and Anderson BD (1992). In: Prodrugs: Topical and Ocular Drug Delivery, Sloan K, (ed.), Marcel Dekker Inc., New York, USA, pp.117161.
22. Kewal K Jain and John M Walker (2008). Drug Delivery System, Chapter No.5; Transdermal Drug Delivery Systems: Skin Perturbation Devices. Humana Press, Totowa, New Jersey, USA, pp.121-130.
23. Klich CM (1992). Jels and Jellies. In: Swarbrick J, Boylan JC (eds.) Encyclopedia of Pharmaceutical Technology, Vol.6. Marcel Dekker Inc., New York, USA, pp.415-439.
24. Larrucea E, Arellano A, Santoyo S and Ygartua P (2001). Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. Eur. J. Pharm. Biopharm., 52: 113-119.
25. Li YZ, Quan YS, Zang L, Jin MN, Kamiyama F, Katsumi H, Yamamoto A and Tsutsumi S (2008). Transdermal delivery of insulin using trypsin as a biochemical enhancer. Biol. Pharm. Bull., 31(8): 1574-1579.
26. Minnaar M (1997). Introduction to emu oil: Fats and oils in human health. In: Minnaar P, Minnaar M, Minnaar P. The Emu Farmers Handbook, Vol.1, Myoni Publishing Co., Groveton, TX, USA, pp.1-16.
27. Mollgaard D (1989). Transdermal Drug Delivery Systems. Marcel Dekker Inc., New York, USA, pp.229-239.
28. Nayak AK, Mohanty B and KK Sen (2010). "Comparative evaluation of in vitro diclofenac sodium permeability across excised mouse skin from different common pharmaceutical vehicles. Int J PharmTech Res, 2(1): 920-930.
29. Nicols DSHW (1960). The biological activity of pure peptides obtamed by enzymatic hydrolysis of insulin. Biochem. J., 75: 395-401.
30. Ongpipattankul B, Burnette RR, Potts RO and Francoeur ML (1991). Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res., 7: 350-354.
31. Patel N and Kostenbauder HB (1958). Interaction of preservatives with macromolecules I: Binding of parahydroxybenzoic acid esters by polyoxyethylene 20 sorbitan monooleate (Tween 80). J. Am. Pharm. Assoc. (Sci), 47: 289-293.
32. Patel VM, Prajapati BG and Patel MM (2007). Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. AAPS PharmSciTech., 8(2): article 45.
33. Pathan IB and Setty CM (2009). Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res, 8(2): 173-179.
34. Pillai O and Panchagnula R (2004). Transdermal iontophoresis of insulin. VI. Influence of pretreatment with fatty acids on permeation across rat skin. Skin Pharmacol Physiol, 17(6): 289-297.
35. Pirot F, Kalia YN, Stinchcomb AL, Keating G, Bunge A and Guy RH (1997). Characterization of the permeability barrier of human skin in vivo. Proc. Nat. Acad. Sci., 94: 1562-1567.
36. Poprzan J and deNavarre MG (1959). The interference of nonionic emulsifiers with preservatives VIII. J. Soc. Cosmet. Chem., 10: 81-87.
37. Potts RO and Guy RH (1992). Predicting skin permeability. Pharm. Res., 9: 663-669.
38. Saha JK, Xia J, Grondin JM, Engle SK and Jakubowski JA (2005). Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: Mechanisms and implications for preclinical models. Exp. Biol. Med. (Maywood), 230(10): 777-784.
39. Sanger F (1960). Chemistry of insulin. Br. Med. Bull., 16: 183-188.
40. Sato A, Friend O and Nagai I (1988). Effect and mode of action of aliphatic esters. Int. J. Pharm., 43: 31-40.
41. Scott RC, Walker M and Dugard PH (1986). In vitro percutaneous absorption experiments. A technique for production of intact epidermal membrane from rat skin, J. Soc. Cosmet. Chem., 37: 35-41.
42. Singh S (1999). Drug stability testing and shelf life determination according to international guidelines. Pharm. Tech., 7: 69-79.
43. Trommer H and Neubert RHH (2006). Overcoming the stratum corneum the modulation of skin penetration. Skin Pharmacol Physiol., 19: 106-121.
44. Zakzewski CA, Wasilewski J, Cawley P and Ford W (1998). Transdermal delivery of regular insulin to chronic diabetic rats: Effect of skin preparation and electrical enhancement. J. Control Release, 2; 50(1-3): 267-272.